Optimizing Regulatory Review Processes with Pinnacle 21 Enterprise

This case study explores how Zhejiang Longcharm Biomedical Technology, a Chinese CRO, enhanced their regulatory review processes using Pinnacle 21 Enterprise. Liming Fang, Deputy General Manager, shares insights on overcoming challenges in data review, improving communication, and ensuring compliance with CDISC standards. The implementation of P21E has streamlined operations, reduced costs, and accelerated new product launches, ultimately benefiting clients and patients alike.